GEODE CAPITAL MANAGEMENT, LLC

Position in KTTA — Pasithea Therapeutics Corp.

CIK 1214717 BOSTON, MA

Position in KTTA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$43,185

-$33,971 QoQ

Shares Held

83,856

-19.4% QoQ

Ownership

0.251%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 25 holders

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. KTTA ranks #482 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$43,185	83,856	-19.4%	Shares	Defined	2026-08-12
2026-03-31	$77,156	103,985	+90.8%	Shares	Defined	2026-05-15
2025-12-31	$70,298	54,495	+113.9%	Shares	Defined	2026-02-09
2025-09-30	$18,647	25,475	-79.6%	Shares	Defined	2025-11-12
2023-12-31	$46,295	125,123	0.0%	Shares	Defined	2024-02-13
2023-09-30	$60,059	125,123	+27.4%	Shares	Defined	2023-11-13
2023-06-30	$48,141	98,248	0.0%	Shares	Defined	2023-08-11
2023-03-31	$36,843	98,248	0.0%	Shares	Defined	2023-05-15
2022-12-31	$63,075	98,248	-0.4%	Shares	Defined	2023-02-13
2022-09-30	$124,234	98,599	+399.8%	Shares	Defined	2022-11-14
2022-06-30	$19,923	19,726	—	Shares	Defined	2022-08-12
No filing history on record for this holder in this stock.